We couldn’t have our blog complete without suggesting our best choices in supplements and vitamins for cancer that can be taken orally.We pick only a few that we have experienced are working.



Active hexose correlated compound(AHCC)

Active Hexose Correlated Compound (AHCC) is an alpha-glucan rich nutritional supplement produced from the mycelia of shiitake (Lentinula edodes) of the basidiomycete family of mushrooms, and is not an approved drug…AHCC was originally designed to lower high-blood pressure. However, researchers at Tokyo University found that AHCC increased natural killer (NK) cell activity in cancer patients, and also enhanced the effects of killer T-cells, and cytokines.

Prognostic improvement of patients with advanced liver cancer after active hexose correlated compound (AHCC) treatment.


Most patients with liver cancer are diagnosed when they are not suitable for resection. Although some palliative approaches can be applied to these patients, the overall survival rate remains unsatisfactory. Active hexose correlated compound (AHCC), a newly developed functional food, has been shown to act as a potent biological response modifier in in vitro experiments. Recently, AHCC was found to improve the prognosis of hepatocellular carcinoma patients following surgical treatment. We investigated whether AHCC could prolong survival and improve the prognosis of patients with advanced liver cancer. A prospective cohort study was performed with 44 patients with histologically confirmed liver cancer. All of the patients underwent supportive care. Survival time, quality of life, clinical and immunological parameters related to liver function, cellular immunity, and patient status were determined. Of the 44 patients, 34 and 10 received AHCC and placebo (control) orally, respectively. Patients in the AHCC treated-group had a significantly prolonged survival when compared to the control group by Mann-Whitney test (95% CI, p = 0.000). Quality of life in terms of mental stability, general physical health status, and ability to have normal activities were significantly improved after 3 months of AHCC treatment when tested using the Wilcoxon signed-rank test (on one-sided test, p = 0.028, 0.037, and 0.040, respectively). The apparent different clinical parameters between the two groups were the levels of albumin and percentage of lymphocytes with p-values of 0.000 and 0.026 at 1 and 2 months after treatment, respectively. Unlike the control patients, AHCC treated-patients with longer survival time had the tendency of better outcomes since the levels of AST and ALT had not increased rapidly from their baselines at follow-up. In addition, the levels of total IL-12 and neopterin were slightly increased in AHCC treated-patients. This study suggests that AHCC intake could prolong the survival and improve the prognosis of patients with advanced liver cancer and delay the gradual decline of their physiological status.

Reduction of adverse effects by a mushroom product, active hexose correlated compound (AHCC) in patients with advanced cancer during chemotherapy–the significance of the levels of HHV-6 DNA in saliva as a surrogate biomarker during chemotherapy.


Chemotherapy improves the outcome of cancer treatment, but patients are sometimes forced to discontinue chemotherapy or drop out of a clinical trial due to adverse effects, such as gastrointestinal disturbances and suppression of bone marrow function. The objective of this study was to evaluate the safety and effectiveness of a mushroom product, active hexose correlated compound (AHCC), on chemotherapy-induced adverse effects and quality of life (QOL) in patients with cancer. Twenty-four patients with cancer received their first cycle of chemotherapy without AHCC and then received their second cycle with AHCC. During chemotherapy, we weekly evaluated adverse effects and QOL via a blood test, EORTC QLQ-C30 questionnaire, and DNA levels of herpes virus type 6 (HHV-6) in saliva. The DNA levels of HHV-6 were significantly increased after chemotherapy. Interestingly, administration of AHCC significantly decreased the levels of HHV-6 in saliva during chemotherapy and improved not only QOL scores in the EORTC QLQ-C30 questionnaire but also hematotoxicity and hepatotoxicity. These findings suggest that salivary HHV-6 levels may be a good biomarker of QOL in patients during chemotherapy, and that AHCC may have a beneficial effect on chemotherapy-associated adverse effects and QOL in patients with cancer undergoing chemotherapy.

Our choice is AHCC from the most reliable brand so far Kinoko

You can buy it here



Graviola, also known by the name of its fruit, sour sop, has received a great deal of attention lately because of its promising compounds as possibly being a natural anti-cancer agent. Graviola (Annona muricata) is an evergreen tree that is used as a remedy for coughs, bacterial and parasite infections, herpes, and arthritis.

A great deal of the excitement over this fruit came from a study done in 2012 in Nebraska at the Department of Biochemistry and Molecular Biology that showed that sour sop was effective against pancreatic cancer cells. These types of cells are extremely resistant to conventional therapies. By inhibiting several signaling pathways that pancreatic cancer cells use to regulate their survival and metastatic lifecycle, graviola kills these cells when they are unable to complete their normal function. Once they are inhibited in this manner, the rate at which pancreatic cancer cells spread to other organs to make new cancers becomes incredibly slow.

Still another study done in Virginia at Virginia Tech, found that sour sop extracts also stopped the growth of breast cancer cells. Sour sop extract also inhibited the growth of EGFR. You should note that cell mutation result in the overproduction of EGFR has been strongly connected to several cancers.

You might have heard a great deal of controversy over sour sop and it’s possibly hyped up claims of its cancer killing abilities. You can read the original study that the makers of sour sop extract claimed were the basis of their product: http://www.ncbi.nlm.nih.gov/pubmed/8991944


You can buy Graviola here


Vitamin D

Vitamin D is critically important in preventing and surviving cancer. For example:

  1. Adequate blood levels of vitamin D can prevent cancer(here, bladder cancer). IARC has confirmed this across a wide range of cancers.
  2. Plasma vitamin D levels can predict survival times in breast cancer. People with low vitamin D levels survive least.
  3. Vitamin D can correct cancer cells –“It can adjust almost everything in the cancer cell, switch genes on and off, reduce cancer cell division and it can cal.m the cells so they settle rather than spread. It seems vitamin D can return cancer cells to a normal and healthy state (Journal of Cell Biology, Nov 17, 2008: 183 (4): 697-710.) 
  4. Vitamin D has Epigenetic benefits – Vitamin D plays a key role in metabolism and nuclear regulation in ageing and cancer. You are not doomed. Epigenetics holds that cancer is reversible.
  5. Vitamin D can slow or reverse prostate cancer in patients
  6. Vitamin D shown to be important in Triple Negative Breast Cancer

Harvard Medical School has been conducting research on vitamin D for over 20 years. Professor Michael Holick is an endocrinologist specialising in vitamin D and he has said that “25% less women would die from breast cancer if they had sufficient vitamin D in their blood”.

Holick is not alone in stressing the importance for women and breast cancer.  St George´s Hospital in London calculated from their studies that women with low levels of vitamin D in their breast tissue have a 354 per cent greater risk of breast cancer. Translated into English this means they have 4 and a half times the breast cancer risk.

But …

Chemotherapy damages vitamin D levels severely

  1. Three studies show Chemotherapy linked to ´severe vitamin D deficiency´

 * Researchers from Roswell Park Cancer Center studying patients with colorectal cancer showed that each of three different chemotherapy regimens, reduced plasma vitamin D levels down to 21.3 ng/ml, where 30-50 is an optimal range.

* Two studies from Dr. William Jacot and colleagues from Montpelier, France with breast cancer showed the same damaging effect. Even though the 18 months of chemo involved two summers, a deficiency in 80 per cent of patients before chemotherapy rose to 97 per cent after. And the average vitamin D level fell from a low 21.3 anyway, to a damaging 14.7 ng/ml. A quarter of the women treated fell below 10 ng/ml. The researchers said vitamin D supplementation should be tailored to the patient.

This begs the question, ´Could all strong drugs for any illness damage vitamin D levels?´ 

Vitamin D is essential to your good health

  1. Vitamin D has been repeatedly linked to bone health, both in the elderly and the young.
  2. Vitamin D appears to reduce type-2 diabetes risk, clinical trials are underway.
  3. Low levels of Vitamin D are linked to increased risk of Alzheimer´s.
  4. Vitamin D reduces the risk of severe Asthma attacks.
  5. Vitamin D can reduce gut inflammation, IBS and colitis.

and low blood levels of vitamin D have been linked to higher risk of strokes, heart attacks, diabetes and multiple sclerosis. As we age we need more of it. There is even some evidence from a meta-analysis of 18 research studies (Annals of Internal Medicine) that vitamin D supplementation can increase longevity.

So, vitamin D – are you getting enough?

As you can see from the above, levels of 20 ng/ml are linked to cancer and levels below 30 ng/ml are seen as a deficiency. A study in 2016 amongst Dutch athletes showed two thirds of them below the norm of 30 ng/ml.

In CANCERactive patients, we encourage the base of 40 ng/ml with, ideally, levels over 70 ng/ml and up to 150 ng/ml.

Having a blood test is the only accurate way of knowing your blood vitamin D levels.


You can buy vitamin d here